… with Leucine Rich Repeat Kinase 2 (LRRK2) mutations to that of the general population. In other words the SGK1 … patients against PD. This study is designed to determine how SGK1 mutants protect LRRK2 mutants against PD. Project … (wild type) and mutant (polymorphic) SGK1 and LRRK2 will be combined in neuronal cells to determine if the mutant SGK1 …

… across the United Kingdom will take part in the Olympic torch relay, leading up to the London 2012 Olympic Games. Among them was Andy Seward … sportsman for much of his life, Seward was inspired to get out of his wheelchair to carry the Olympic flame through …

… Markers Initiative (PPMI) study expands recruitment to Canada to help speed cures and disease prevention … — the Foundation’s landmark study to learn more about how Parkinson’s starts, how it changes over time and how to … the full spectrum of disease and its need for everyone to become an active participant in being part of the solution. …

… for Americans with Parkinson’s disease (PD): Pharmaceutical company UCB has announced that Neupro, an extended-release … when a manufacturing problem made it impossible for UCB to guarantee proper dosing. This past April, UCB announced … had already been re-approved in the European Union. Here’s how the patch works: Dopamine agonists mimic how dopamine …

…   Did you ever wonder what it’s like to own a race car team? Now you can find out through the … Whelen Racing drivers Boris Said and Eric Curran, hotel accommodations and VIP pit passes. One hundred percent of the … the Danville d’Elegance Foundation hosts a classic car show each year in Danville, CA, an event that was among Team …

… Study Rationale: Inadequate understanding of how Parkinson's disease develops is a major roadblock in developing effective therapeutics and methods to diagnose the disease earlier.  This project directly … multiple Parkinson's patients and age-matched controls and compare their specific characteristics, in terms of growth, …